| __timestamp | ACADIA Pharmaceuticals Inc. | Blueprint Medicines Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 31844000 |
| Thursday, January 1, 2015 | 73869000 | 48588000 |
| Friday, January 1, 2016 | 99284000 | 81131000 |
| Sunday, January 1, 2017 | 149189000 | 144687000 |
| Monday, January 1, 2018 | 187163000 | 243621000 |
| Tuesday, January 1, 2019 | 240385000 | 331450000 |
| Wednesday, January 1, 2020 | 319130000 | 326860000 |
| Friday, January 1, 2021 | 239415000 | 601033000 |
| Saturday, January 1, 2022 | 361575000 | 477419000 |
| Sunday, January 1, 2023 | 351619000 | 427720000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and ACADIA Pharmaceuticals Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Blueprint Medicines increased its R&D expenses by over 1,200%, peaking in 2021 with a remarkable 601 million dollars. Meanwhile, ACADIA Pharmaceuticals saw a 480% rise, reaching its highest expenditure in 2022. Notably, Blueprint Medicines consistently outspent ACADIA from 2018 onwards, highlighting its aggressive pursuit of innovation.
This trend underscores the growing importance of R&D in the biotech sector, as companies strive to develop groundbreaking therapies. As we look to the future, these investments are likely to yield significant advancements in healthcare, benefiting patients worldwide.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.